CAPRICOR THERAPEUTICS INC - COM (CAPR)

CUSIP: 14070B101

Q3 2018 13F Holders as of 30 Sep 2018

Type / Class
Equity / COM
Total 13F shares
2,175,953
Share change
-246,553
Total reported value
$2,284,000
Price per share
$1.05
Number of holders
17
Value change
-$263,782
Number of buys
5
Number of sells
5

Quarterly Holders Quick Answers

What is CUSIP 14070B101?
CUSIP 14070B101 identifies CAPR - CAPRICOR THERAPEUTICS INC - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of CAPRICOR THERAPEUTICS INC - COM (CAPR) as of Q3 2018

As of 30 Sep 2018, CAPRICOR THERAPEUTICS INC - COM (CAPR) was held by 17 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 2,175,953 shares. The largest 10 holders included BROWN ADVISORY INC, Vanguard Group Inc, LLBH Private Wealth Management, LLC, GEODE CAPITAL MANAGEMENT, LLC, Apriem Advisors, NORTHERN TRUST CORP, BlackRock Inc., Bank of New York Mellon Corp, CITADEL ADVISORS LLC, and Virtu Financial LLC. This page lists 17 institutional shareholders reporting positions in this security for the Q3 2018 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.